TD Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $853M | Sell |
3,920,076
-240,440
| -6% | -$53.3M | 0.69% | 35 |
|
|
2025
Q4 | $951M | Sell |
4,160,516
-97,811
| -2% | -$22.3M | 0.76% | 29 |
|
|
2025
Q3 | $986M | Buy |
4,258,327
+522,512
| +14% | +$106M | 0.8% | 26 |
|
|
2025
Q2 | $693M | Buy |
3,735,815
+512,440
| +16% | +$95.2M | 0.59% | 35 |
|
|
2025
Q1 | $675M | Buy |
3,223,375
+531,156
| +20% | +$103M | 0.62% | 34 |
|
|
2024
Q4 | $478M | Sell |
2,692,219
-1,002,561
| -27% | -$184M | 0.42% | 49 |
|
|
2024
Q3 | $720M | Buy |
3,694,780
+144,260
| +4% | +$26.9M | 0.64% | 31 |
|
|
2024
Q2 | $609M | Buy |
3,550,520
+76,500
| +2% | +$12.7M | 0.57% | 38 |
|
|
2024
Q1 | $633M | Buy |
3,474,020
+2,116,997
| +156% | +$365M | 0.59% | 36 |
|
|
2023
Q4 | $210M | Buy |
1,357,023
+221,463
| +20% | +$32.3M | 0.21% | 93 |
|
|
2023
Q3 | $169M | Buy |
1,135,560
+35,481
| +3% | +$5.21M | 0.21% | 89 |
|
|
2023
Q2 | $148M | Sell |
1,100,079
-6,001
| -0.5% | -$880K | 0.17% | 108 |
|
|
2023
Q1 | $176M | Buy |
1,106,080
+197,090
| +22% | +$30.1M | 0.21% | 92 |
|
|
2022
Q4 | $147M | Buy |
908,990
+5,154
| +0.6% | +$790K | 0.18% | 110 |
|
|
2022
Q3 | $129M | Sell |
903,836
-30,330
| -3% | -$4.35M | 0.16% | 110 |
|
|
2022
Q2 | $143M | Sell |
934,166
-36,809
| -4% | -$5.62M | 0.17% | 110 |
|
|
2022
Q1 | $157M | Sell |
970,975
-40,548
| -4% | -$5.89M | 0.14% | 128 |
|
|
2021
Q4 | $137M | Sell |
1,011,523
-21,813
| -2% | -$2.58M | 0.11% | 154 |
|
|
2021
Q3 | $111M | Sell |
1,033,336
-19,140
| -2% | -$2.19M | 0.12% | 138 |
|
|
2021
Q2 | $122M | Sell |
1,052,476
-53,189
| -5% | -$5.99M | 0.12% | 140 |
|
|
2021
Q1 | $120M | Buy |
1,105,665
+40,649
| +4% | +$4.35M | 0.13% | 128 |
|
|
2020
Q4 | $114M | Buy |
1,065,016
+53,124
| +5% | +$5.11M | 0.14% | 135 |
|
|
2020
Q3 | $88.6M | Buy |
1,011,892
+136,853
| +16% | +$12.9M | 0.12% | 148 |
|
|
2020
Q2 | $85.9M | Buy |
875,039
+26,083
| +3% | +$2.3M | 0.12% | 144 |
|
|
2020
Q1 | $64.7M | Buy |
848,956
+88,535
| +12% | +$7.54M | 0.11% | 154 |
|
|
2019
Q4 | $67.3M | Buy |
760,421
+48,226
| +7% | +$4M | 0.1% | 175 |
|
|
2019
Q3 | $53.9M | Buy |
712,195
+86,817
| +14% | +$5.95M | 0.08% | 201 |
|
|
2019
Q2 | $45.5M | Buy |
625,378
+6,931
| +1% | +$545K | 0.07% | 221 |
|
|
2019
Q1 | $49.8M | Sell |
618,447
-109,152
| -15% | -$8.93M | 0.08% | 205 |
|
|
2018
Q4 | $67.1M | Sell |
727,599
-3,386
| -0.5% | -$298K | 0.12% | 148 |
|
|
2018
Q3 | $69.1M | Sell |
730,985
-51,946
| -7% | -$4.93M | 0.1% | 168 |
|
|
2018
Q2 | $72.5M | Sell |
782,931
-786,899
| -50% | -$76.9M | 0.11% | 157 |
|
|
2018
Q1 | $149M | Sell |
1,569,830
-1,162,019
| -43% | -$128M | 0.23% | 84 |
|
|
2017
Q4 | $264M | Sell |
2,731,849
-68,742
| -2% | -$6.48M | 0.38% | 49 |
|
|
2017
Q3 | $249M | Sell |
2,800,591
-55,811
| -2% | -$4.25M | 0.37% | 52 |
|
|
2017
Q2 | $207M | Sell |
2,856,402
-64,139
| -2% | -$4.31M | 0.33% | 56 |
|
|
2017
Q1 | $190M | Buy |
2,920,541
+57,134
| +2% | +$3.59M | 0.3% | 62 |
|
|
2016
Q4 | $179M | Buy |
2,863,407
+42,673
| +2% | +$2.6M | 0.3% | 61 |
|
|
2016
Q3 | $178M | Buy |
2,820,734
+31,728
| +1% | +$2.05M | 0.31% | 63 |
|
|
2016
Q2 | $173M | Sell |
2,789,006
-839,060
| -23% | -$51.1M | 0.31% | 64 |
|
|
2016
Q1 | $207M | Sell |
3,628,066
-529,994
| -13% | -$29.5M | 0.39% | 50 |
|
|
2015
Q4 | $246M | Buy |
4,158,060
+282,852
| +7% | +$16.3M | 0.49% | 42 |
|
|
2015
Q3 | $211M | Sell |
3,875,208
-93,280
| -2% | -$6.07M | 0.42% | 47 |
|
|
2015
Q2 | $267M | Buy |
3,968,488
+1,348,953
| +51% | +$88.1M | 0.48% | 42 |
|
|
2015
Q1 | $153M | Buy |
2,619,535
+1,104,183
| +73% | +$66.7M | 0.28% | 67 |
|
|
2014
Q4 | $99.2M | Buy |
1,515,352
+115,245
| +8% | +$7.27M | 0.17% | 116 |
|
|
2014
Q3 | $80.9M | Buy |
1,400,107
+110,957
| +9% | +$6.16M | 0.14% | 128 |
|
|
2014
Q2 | $72.8M | Buy |
1,289,150
+1,147
| +0.1% | +$60.2K | 0.12% | 136 |
|
|
2014
Q1 | $66.2M | Sell |
1,288,003
-119,407
| -8% | -$6.03M | 0.12% | 141 |
|
|
2013
Q4 | $74.3M | Sell |
1,407,410
-36,999
| -3% | -$1.82M | 0.14% | 131 |
|
|
2013
Q3 | $64.6M | Buy |
1,444,409
+52,867
| +4% | +$2.34M | 0.13% | 135 |
|
|
2013
Q2 | $57.5M | Buy |
+1,391,542
| New | +$60.9M | 0.12% | 135 |
|
Other funds holding ABBV
VCM
VPM
TD Asset Management's ABBV Position: Q1 2026 in Review
TD Asset Management reduced its AbbVie (ABBV) stake by 5.8% in Q1 2026, selling an estimated $53.3M and leaving 3,920,076 shares worth $853M. The position accounts for 0.69% of the portfolio, ranked #35.
TD Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $986M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- TD Asset Management held 3,920,076 shares of AbbVie worth $853M as of Q1 2026.
- TD Asset Management sold 240,440 AbbVie shares in Q1 2026, an estimated $53.3M.
- AbbVie made up 0.69% of TD Asset Management's portfolio in Q1 2026, its #35 holding.
- TD Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- TD Asset Management's AbbVie position peaked at $986M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.